Prostatic Size Reduction Following of Leuprorelin Acetate
Recruiting · NCT06184464 · Observational (researchers observe without assigning treatment) · Lead sponsor: Consorci Sanitari de Terrassa
View the official record on ClinicalTrials.gov →Interventions studied
ACETATE LEUPRELINE
What this trial is about
To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.
Who can take part
Age range
18 Years to 95 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Man with Prostate positive biopsy. Able to Ssgned informed consent form. Need of hormonal treatment before start of radiotherapy
Exclusion criteria
- Patients With prostate size of less than 20 cc at diagnosis. Patients With Positive lymph nodes or metastatic prostate cancer disease on imaging studies.
- Patients with Previous pelvic radiation therapy.
Where it is running
1 location listed.
- Hospital de Terrassa - Terrassa, Barcelona, Spain